Drugs / Clostridium Histolyticum Collagenase
last change Apr 2023 re-read 3 minutes ago

Clostridium Histolyticum Collagenase

Developed for
urethral stricture
Investigated by
University of South Florida

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02948842 May 2020 → Mar 2023 urethral stricture University of South Florida Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Clostridium Histolyticum Collagenase ClinicalTrials.gov intervention name — accepted as the source's own label NCT02948842 ↗
Route Other “transurethral injection” NCT02948842 ↗